These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23639740)

  • 1. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
    Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
    Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.
    Dusaulcy R; Rancoule C; Grès S; Wanecq E; Colom A; Guigné C; van Meeteren LA; Moolenaar WH; Valet P; Saulnier-Blache JS
    J Lipid Res; 2011 Jun; 52(6):1247-1255. PubMed ID: 21421848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice.
    Rancoule C; Attané C; Grès S; Fournel A; Dusaulcy R; Bertrand C; Vinel C; Tréguer K; Prentki M; Valet P; Saulnier-Blache JS
    Diabetologia; 2013 Jun; 56(6):1394-402. PubMed ID: 23508306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.
    D'Souza K; Nzirorera C; Cowie AM; Varghese GP; Trivedi P; Eichmann TO; Biswas D; Touaibia M; Morris AJ; Aidinis V; Kane DA; Pulinilkunnil T; Kienesberger PC
    J Lipid Res; 2018 Oct; 59(10):1805-1817. PubMed ID: 30072447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity.
    Sun S; Wang R; Song J; Guan M; Li N; Zhang X; Zhao Z; Zhang J
    J Lipid Res; 2017 Nov; 58(11):2102-2113. PubMed ID: 28874440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secretion and role of autotaxin and lysophosphatidic acid in adipose tissue].
    Saulnier-Blache JS
    J Soc Biol; 2006; 200(1):77-81. PubMed ID: 17144165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
    Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
    J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
    Ferry G; Tellier E; Try A; Grés S; Naime I; Simon MF; Rodriguez M; Boucher J; Tack I; Gesta S; Chomarat P; Dieu M; Raes M; Galizzi JP; Valet P; Boutin JA; Saulnier-Blache JS
    J Biol Chem; 2003 May; 278(20):18162-9. PubMed ID: 12642576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
    D'Souza K; Paramel GV; Kienesberger PC
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence.
    Rancoule C; Viaud M; Gres S; Viguerie N; Decaunes P; Bouloumié A; Langin D; Bascands JL; Valet P; Saulnier-Blache JS
    Biochim Biophys Acta; 2014 Jan; 1841(1):88-96. PubMed ID: 24120919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.
    Boucher J; Quilliot D; Pradères JP; Simon MF; Grès S; Guigné C; Prévot D; Ferry G; Boutin JA; Carpéné C; Valet P; Saulnier-Blache JS
    Diabetologia; 2005 Mar; 48(3):569-77. PubMed ID: 15700135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity.
    Fayyaz S; Japtok L; Schumacher F; Wigger D; Schulz TJ; Haubold K; Gulbins E; Völler H; Kleuser B
    Cell Physiol Biochem; 2017; 43(2):445-456. PubMed ID: 28922661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity Resistance and Enhanced Insulin Sensitivity in Ahnak-/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy Expenditure.
    Shin JH; Kim IY; Kim YN; Shin SM; Roh KJ; Lee SH; Sohn M; Cho SY; Lee SH; Ko CY; Kim HS; Choi CS; Bae YS; Seong JK
    PLoS One; 2015; 10(10):e0139720. PubMed ID: 26466345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
    Yang F; Chen GX
    World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.
    Jose A; Kienesberger PC
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin Is Regulated by Glucose and Insulin in Adipocytes.
    D'Souza K; Kane DA; Touaibia M; Kershaw EE; Pulinilkunnil T; Kienesberger PC
    Endocrinology; 2017 Apr; 158(4):791-803. PubMed ID: 28324037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
    Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
    BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotaxin and chronic inflammatory diseases.
    Magkrioti C; Galaris A; Kanellopoulou P; Stylianaki EA; Kaffe E; Aidinis V
    J Autoimmun; 2019 Nov; 104():102327. PubMed ID: 31471142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice.
    Federico L; Ren H; Mueller PA; Wu T; Liu S; Popovic J; Blalock EM; Sunkara M; Ovaa H; Albers HM; Mills GB; Morris AJ; Smyth SS
    Mol Endocrinol; 2012 May; 26(5):786-97. PubMed ID: 22474126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.